Incannex Healthcare (IXHL) Total Current Liabilities (2020 - 2026)
Incannex Healthcare's (IXHL) quarterly Total Current Liabilities came in at $1.9 million in Q1 2026, down 73.85% year-on-year from $7.4 million in Q1 2025, and up 24.56% quarter-over-quarter from $1.5 million in Q4 2025.
Incannex Healthcare (IXHL) Total Current Liabilities (2020 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Total Current Liabilities across 7 years of filings, most recently posting $1.9 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $1.9 million, down 73.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (down 73.85% YoY), and the FY2025 annual result was $7.0 million, up 24.27% from the prior year.
- Total Current Liabilities came in at $1.9 million for Q1 2026 at Incannex Healthcare, up from $1.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $9.2 million in Q3 2024 to a low of $1.5 million in Q4 2025.
- The 5-year median for Total Current Liabilities is $3.0 million (2023), against an average of $4.2 million.
- Across the five-year window, Total Current Liabilities soared 166.28% in 2022 and plunged 82.15% in 2025, its largest moves.
- Incannex Healthcare's Total Current Liabilities stood at $2.0 million in 2022, then jumped by 58.47% to $3.2 million in 2023, then soared by 83.3% to $5.8 million in 2024, then tumbled by 73.51% to $1.5 million in 2025, then increased by 24.56% to $1.9 million in 2026.
- The last three Total Current Liabilities figures came in at $1.9 million (Q1 2026), $1.5 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | 1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 6.98 Mn |
| Mar 31, 2025 | 7.37 Mn |
| Dec 31, 2024 | 5.84 Mn |
| Sep 30, 2024 | 9.23 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 2.86 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Jun 30, 2021 | 755,049.00 |
| Jun 30, 2020 | 1.07 Mn |